Published :
Tables : 65
Figures : 50
Category : Healthcare
No. of Pages : 240
Report Code : HC-U3261
Antimicrobial Susceptibility Testing Market is predicted to value over USD 3.9 billion by 2027 end with a CAGR of over 5% during the forecast period 2020 to 2027. Increased occurrence of infectious diseases worldwide, the initiation of antimicrobial resistance owing to drug overuse, rising initiatives by the government for controlling and detecting species with antimicrobial resistance are some of the major driving factors contributing to the antimicrobial susceptibility testing market growth. There has been a rising insistence for clinical microbiology testing procedures over the last few years leading to a steady proliferation of the market. Furthermore, with the rising prevalence of infectious diseases, the insistence for clinical microbiology processes for antimicrobial susceptibility and microbial identification testing for pathogens is predicted to experience substantial growth throughout the forecasted timeframe. With an extensive information available over bacterial pathogens and their susceptibility towards antimicrobials, it shall help in adopting appropriate therapies which is important for managing diseases. According to multiple reports published by WHO, over 28,000 Ebola virus cases were reported in March 2016 and the countries affected by this virus were the United States, Italy, Spain, Nigeria, Senegal, Liberia, Mali, Sierra Leone and Guinea. Furthermore, over 10 million people were predicted to be diagnosed with tuberculosis in 2016 and over 1.6 million people died owing to tuberculosis. Similarly, in 2015, over 210 million were affected by malaria with over 85% deaths recorded in Africa. Such statistics states the growing prevalence of epidemics across the world, thereby increasing the antimicrobial susceptibility testing market demand. The medical reimbursements for microbial testing are scarcely available is one of the primary factors impeding the market growth. Moreover, the emergence of expensive antimicrobial products has severely affected the growth of the market, especially in the United States. The healthcare services coding provides the medical reimbursements in the Unites States and these are looked after by the American Medical Association combined with the International Classification of Diseases codes. With such stringent regulations for reimbursements, the market growth is likely to be impeded during the forecast period. Market Segmentation: By Product Automated Laboratory Instruments Manual Antimicrobial Susceptibility Testing Products Susceptibility Testing Disks MIC Strips Susceptibility Plates Culture and Growth Media Consumables By Method Dilution Disk Diffusion ETEST Automated Antimicrobial Susceptibility Testing Genotypic Methods By Type Antibacterial Testing Antifungal Testing Antiparasitic Testing Other Susceptibility Testing By Application Clinical Diagnostics Drug Discovery and Development Epidemiology Other Applications By End User Diagnostic Centers and Hospitals Pharmaceutical and Biotechnology Companies Contract Research Organizations (CROs) Research and Academic Institutes By Region North America Europe Asia-Pacific Latin America Middle East and Africa The manual antimicrobial susceptibility segment is anticipated to lead the market owing to advantages like low cost, reduced cost of labour, ease of use. The disk diffusion segment is predicted to account the largest antimicrobial susceptibility testing market share owing to the economy and flexibility of these techniques. The antibacterial testing segment is estimated to dominate the market, and this is mainly due to a rising occurrence of infections owing to bacterial pathogens and rising stringencies with guidelines. Regional Analysis: The North America region is predicted to lead the market during the forecast period owing to ease of access and rising acceptance of advanced technologies pertaining to susceptibility testing products and methods. Furthermore, rising antimicrobial resistance in North America is another crucial factor contributing to the market growth in the region. Competitive Landscape: The key market players associated are bioMérieux , BD, Danaher, Thermo Fisher, Bio-Rad Laboratories, Hi-Media, MERLIN, Liofilchem, Accelerate, Alifax, Creative Diagnostics, Merck Group, Synbiosis, Bioanalyse, Zhuhai DL Biotech. FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global antimicrobial susceptibility testing market by product, by method, by type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased occurrence of infectious diseases worldwide, the initiation of antimicrobial resistance owing to drug overuse, rising initiatives by the government for controlling and detecting species with antimicrobial resistance are some of the major driving factors contributing to the antimicrobial susceptibility testing market growth. There has been a rising insistence for clinical microbiology testing procedures over the last few years leading to a steady proliferation of the market. Furthermore, with the rising prevalence of infectious diseases, the insistence for clinical microbiology processes for antimicrobial susceptibility and microbial identification testing for pathogens is predicted to experience substantial growth throughout the forecasted timeframe. With an extensive information available over bacterial pathogens and their susceptibility towards antimicrobials, it shall help in adopting appropriate therapies which is important for managing diseases.
According to multiple reports published by WHO, over 28,000 Ebola virus cases were reported in March 2016 and the countries affected by this virus were the United States, Italy, Spain, Nigeria, Senegal, Liberia, Mali, Sierra Leone and Guinea. Furthermore, over 10 million people were predicted to be diagnosed with tuberculosis in 2016 and over 1.6 million people died owing to tuberculosis. Similarly, in 2015, over 210 million were affected by malaria with over 85% deaths recorded in Africa. Such statistics states the growing prevalence of epidemics across the world, thereby increasing the antimicrobial susceptibility testing market demand.
The medical reimbursements for microbial testing are scarcely available is one of the primary factors impeding the market growth. Moreover, the emergence of expensive antimicrobial products has severely affected the growth of the market, especially in the United States. The healthcare services coding provides the medical reimbursements in the Unites States and these are looked after by the American Medical Association combined with the International Classification of Diseases codes. With such stringent regulations for reimbursements, the market growth is likely to be impeded during the forecast period.
Market Segmentation:
By Product
By Method
By Type
By Application
By End User
By Region
The manual antimicrobial susceptibility segment is anticipated to lead the market owing to advantages like low cost, reduced cost of labour, ease of use. The disk diffusion segment is predicted to account the largest antimicrobial susceptibility testing market share owing to the economy and flexibility of these techniques. The antibacterial testing segment is estimated to dominate the market, and this is mainly due to a rising occurrence of infections owing to bacterial pathogens and rising stringencies with guidelines.
Regional Analysis:
The North America region is predicted to lead the market during the forecast period owing to ease of access and rising acceptance of advanced technologies pertaining to susceptibility testing products and methods. Furthermore, rising antimicrobial resistance in North America is another crucial factor contributing to the market growth in the region.
Competitive Landscape:
The key market players associated are bioMérieux , BD, Danaher, Thermo Fisher, Bio-Rad Laboratories, Hi-Media, MERLIN, Liofilchem, Accelerate, Alifax, Creative Diagnostics, Merck Group, Synbiosis, Bioanalyse, Zhuhai DL Biotech.
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.1.1. Increasing focus of Antimicrobial Susceptibility Testing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2 Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3 Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Antimicrobial Susceptibility Testing Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Automated Laboratory Instruments 7.2 Manual Antimicrobial Susceptibility Testing Products 7.3 Susceptibility Testing Disks 7.4 MIC Strips 7.5 Susceptibility Plates 7.6 Culture and Growth Media 7.7 Consumables 8. Antimicrobial Susceptibility Testing Market, By Method Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Dilution 8.2 Disk Diffusion 8.3 ETEST 8.4 Automated Antimicrobial Susceptibility Testing 8.5 Genotypic Methods 9. Antimicrobial Susceptibility Testing Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Antibacterial Testing 9.2 Antifungal Testing 9.3 Antiparasitic Testing 9.4 Other Susceptibility Testing 10. Antimicrobial Susceptibility Testing Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 10.1 Clinical Diagnostics 10.2 Drug Discovery and Development 10.3 Epidemiology 10.4 Other Applications 11. Antimicrobial Susceptibility Testing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 11.1 Diagnostic Centers and Hospitals 11.2 Pharmaceutical and Biotechnology Companies 11.3 Contract Research Organizations (CROs) 11.4 Research and Academic Institutes 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1. U.S. 12.2.2. Canada 12.2.3. Mexico 12.2.4. Rest of North America 12.3 Market Size (USD Mn) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5 Switzerland 14.2.6. Spain 14.2.7. Russia 14.2.8. Poland 14.2.9. Rest of Western Europe 14.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 15.2.1 Japan 15.2.2 China 15.2.3 Singapore 15.2.4 Korea 15.2.5 India 15.2.6 Australia and New Zealand 15.2.7 ASEAN 15.2.8 Rest of Asia Pacific 15.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1 UAE 16.2 South Africa 16.3 Egypt 16.4 Saudi Arabia 16.5 Rest of MEA 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1 bioMérieux 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 Danaher 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 Thermo Fisher 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Bio-Rad 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Hi-Media 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 MERLIN 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 Liofilchem 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 Accelerate 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 Alifax 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.9.6. Creative Diagnostics 17.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11 Merck Group 17.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12 Synbiosis 17.12.1. Company Overview (HQ, Business Segments, Employee Strength) 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13 Bioanalyse 17.13.1. Company Overview (HQ, Business Segments, Employee Strength) 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14 Zhuhai DL Biotech 17.14.1. Company Overview (HQ, Business Segments, Employee Strength) 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 18. Impact of COVID-19 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. Competitive Intelligence and Competitive Matrix 19.1 Competitive Intelligence 19.2 Competitive Matrix 20. Major Deals and Strategic Alliances Analysis 20.1 Joint ventures 20.2 Mergers and acquisitions 20.3 Licensing and partnerships 20.4 Technology Collaborations 20.5 Strategic Divestments 20.6 Market Entry Strategies 21. Relevant Case Studies and Latest News Updates 22. Research Sources and List of Primary Contacts of this Study 23. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics